Cerebral amyloid angiopathy, or CAA, is a disease of the brain's blood vessels. It occurs when a protein called amyloid-beta - the same protein involved in Alzheimer's disease - accumulates inside the walls of the brain's smallest blood vessels. These vessels typically act as drainage pipes, removing waste proteins from the brain. In CAA, this drainage system fails. Instead of being cleared away, amyloid becomes trapped in the vessel walls, gradually making them thick, stiff, and fragile.
As this process continues, the blood vessels become prone to leaking and breaking. This is why CAA is one of the most common causes of bleeding in the outer regions of the brain in older adults. Even when major bleeding does not occur, these damaged vessels cannot support the surrounding brain tissue as effectively, which can contribute to cognitive decline over time.
CAA exists on a spectrum. Some people have mild disease and never develop symptoms, while others experience repeated small bleeds, brain inflammation, or gradual problems with thinking, balance, or vision.
Why did this happen to me?
CAA is not caused by anything you did. It is primarily related to aging and brain biology. As we age, the brain's ability to clear amyloid declines. In individuals prone to Alzheimer's disease, this clearance system is especially impaired, which is why Alzheimer's and CAA often occur together.
Most people with CAA develop it sporadically later in life. Rare inherited forms exist but are uncommon.
High blood pressure does not cause CAA, but once CAA is present, even mild blood-pressure elevations significantly increase the risk of bleeding.
What symptoms does CAA cause?
Many people with CAA have no symptoms at all. The condition is often discovered when an MRI is conducted for memory concerns, dizziness, or another reason. When symptoms occur, they usually fall into four categories.
The most serious is brain bleeding. CAA weakens surface blood vessels, which can rupture and cause sudden neurological symptoms such as weakness, speech difficulty, vision loss, headache, confusion, or loss of consciousness. These bleeds typically occur in the outer parts of the brain rather than deep structures.
Some people experience brief, stroke-like episodes that come and go. These may include tingling, numbness, weakness, visual distortion, or speech difficulty that resolves within minutes or hours. These are called amyloid-related spells and are caused by tiny leaks of blood irritating the brain surface rather than true strokes.
CAA can also cause cognitive changes, including slowed thinking, attention problems, memory loss, and difficulty with visual-spatial tasks. This happens because repeated microscopic vessel injury disrupts brain networks and because CAA frequently overlaps with Alzheimer's disease.
In some patients, CAA triggers brain inflammation, leading to headaches, seizures, confusion, or rapid cognitive decline. This form is especially important because it is often treatable.
How do doctors know I have CAA?
CAA is diagnosed using MRI of the brain. Special MRI sequences can detect:
- Tiny old bleeds (microbleeds)
- Larger hemorrhages
- Old blood on the brain surface (superficial siderosis)
- White-matter injury
Doctors use established MRI criteria to diagnose CAA with high accuracy. In some cases, amyloid PET scans or blood and spinal-fluid biomarkers are used to determine whether Alzheimer's disease is also present.
A brain biopsy or autopsy is the only way to be 100 percent certain, but modern MRI is usually sufficient.
Does CAA mean I will have a major brain bleed?
Not necessarily. Many people live for years with CAA and never experience a large hemorrhage. However, CAA does increase bleeding risk, especially if blood pressure is not tightly controlled.
The most important protective step is excellent blood-pressure management. Even modestly elevated pressure puts extra strain on fragile vessels. Studies show that good blood-pressure control can reduce CAA-related brain bleeding by more than 70 percent.
Avoiding unnecessary blood thinners and treating sleep apnea, diabetes, and cholesterol further reduces risk.
What if I have already had a bleed?
A prior bleed increases the risk of another one, but it does not mean another is inevitable. Many people recover well and remain stable for years, especially when vascular risk factors are tightly controlled.
Your MRI pattern helps doctors estimate your personal risk. Bleeds that stay near the surface and do not reach the brain's ventricles tend to have better outcomes.
Is there a treatment for CAA?
There is not yet a medication that removes amyloid from blood vessels, but there is a great deal that can be done to protect the brain.
Treatment focuses on:
- Strict blood-pressure control
- Avoiding or carefully weighing blood thinners
- Treating sleep apnea
- Managing cholesterol and diabetes
- Preventing falls and head injury
- Supporting brain health with exercise, nutrition, and cognitive activity
If inflammatory CAA is present, steroids or immune-modulating medications can dramatically improve symptoms and MRI findings.
New therapies aimed at amyloid removal, vessel protection, and immune modulation are actively being studied in clinical trials.
What does this mean for my future?
CAA is a chronic condition, but it is not a singular fixed outcome. Some people remain stable for many years, while others experience periods of activity followed by quiet phases. The future depends on age, MRI findings, blood-pressure control, and whether Alzheimer's disease is also present.
CAA does carry a higher risk of recurrent bleeding than other types of hemorrhage, but careful management can greatly reduce that risk.
Many people with CAA continue to live meaningful, independent lives with the right monitoring and care.
What should I and my family focus on now?
You should understand:
- How active your CAA is on MRI
- Whether Alzheimer's disease is also present
- What your blood-pressure target should be
- Which medications are safe and which should be avoided
- Whether you qualify for specialized care or research studies
CAA is a disease of blood vessels, but it is also a disease of opportunity. With modern imaging, careful management, and rapidly advancing research, the ability to protect the brain is stronger than ever.